US

MIT Solve targets $30 mln for fund

MIT Solve, an initiative of Massachusetts Institute of Technology, is seeking to raise $30 million for its new philanthropic venture fund that focuses on early-stage entrepreneurs solving global challenges. Noubar Afeyan, founder and CEO of Flagship Pioneering and MIT Corporation member, is committing up to $3 million to the fund.

Flexe nabs $43 mln Series B

Seattle-based Flexe, a provider of on-demand warehousing and fulfillment solutions, has raised $43 million in Series B funding. Activate Capital and Tiger Global Management led the round with participation from other investors that included Madrona Venture Group, Redpoint Ventures and Prologis Ventures. In conjunction, Raj Atluru, managing director at Activate Capital, joins the Flexe board.

Radical Ventures unveils $350 mln AI-focused fund

Radical Ventures has launched a $350 million fund focused mostly on artificial intelligence. The fund's limited partners include Canada Pension Plan Investment Board, the Public Sector Pension Investment Board, TD Bank Group and Wittington Investments Limited.

AP Ventures backs Greyrock

Sacramento-based Greyrock Energy Inc, a provider of small scale gas-to-liquids technology, has raised an undisclosed amount of funding. The investor was AP Ventures.

Precise dosage vaporizer Indose locks in $3.5 mln Series A

Indose, a precise dosage vaporizer, has raised $3.5 million in Series A funding. Casa Verde Capital led the round.

Repair Biotechnologies procures $2.15 mln seed

Syracuse, New York-based Repair Biotechnologies Inc has secured $2.15 million in seed funding. Jim Mellon, the billionaire investor and chairman of Juvenescence Ltd, led the round with participation from Emerging Longevity Ventures, Thynk Capital and SENS Research Foundation.

K-Zen Beverages rakes $5 mln seed

Burlingame, California-based K-Zen Beverages, a maker of cannabis-infused drinks, has secured $5 million in seed funding. The investor was DCM.

GV leads Series A round for Verve Therapeutics

Cambridge, Massachusetts-based Verve Therapeutics, a next-generation cardiovascular company, has raised $58.5 million in Series A funding. GV led the round with participation from ARCH Venture Partners, F-Prime Capital and Biomatics Capital.

Board management platform Boardable inks $1 mln seed

Indianapolis-based Boardable, an online board management platform, has secured $1 million in seed funding. The investor was High Alpha Capital. In conjunction with the funding, Eric Tobias, a partner at High Alpha, will join Boardable's board of directors.

Tourlane snags $47 mln

Berlin-based Tourlane, a planning and booking service for trips, has secured $47 million in funding. Sequoia and Spark Capital led the round with participation from DN Capital and HV Holtzbrinck Ventures.